US Stock MarketDetailed Quotes

HEPION PHARMACEUTICALS INC PREFERRED STOCK (CTRVP)

Watchlist
  • 0.0013
  • 0.00000.00%
15min DelayClose Aug 14 14:10 ET
2.19Market Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HEPION PHARMACEUTICALS INC PREFERRED STOCK (CTRVP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
82.04%-3.27M
71.14%-332.78K
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.45%-18.22M
87.19%-1.15M
77.59%-2.52M
12.12%-10.93M
55.97%-3.62M
Net income from continuing operations
37.25%-8.28M
57.55%-656.89K
90.29%-472.51K
73.44%-1.04M
-113.96%-6.11M
73.04%-13.19M
86.01%-1.55M
53.78%-4.87M
72.12%-3.93M
78.48%-2.85M
Operating gains losses
173.30%4.09M
103.23%34.62K
29.31%-47.28K
78.71%-698.07K
513.60%4.8M
-523.43%-5.58M
---1.07M
---66.88K
---3.28M
---1.16M
Depreciation and amortization
--0
--0
--0
--0
--0
-54.18%30.76K
--0
--0
--0
70.53%30.76K
Deferred tax
----
----
----
----
----
--0
----
----
----
----
Other non cash items
----
----
----
----
----
512.70%1.82M
405.48%794.25K
438.98%474.57K
-1,313.48%-1.25M
3,610.29%1.8M
Change In working capital
118.38%493.05K
552.92%289.49K
-96.14%73.82K
98.50%-37.46K
107.83%167.2K
-190.30%-2.68M
102.28%44.34K
310.84%1.91M
-190.26%-2.5M
-170.07%-2.14M
-Change in prepaid assets
-73.55%491.62K
-39.37%177.27K
-92.79%161.91K
114.49%151.09K
-99.63%1.34K
-30.51%1.86M
135.99%292.36K
368.68%2.24M
-298.98%-1.04M
-85.34%364.26K
-Change in payables and accrued expense
100.03%1.43K
145.18%112.22K
73.25%-88.09K
87.18%-188.55K
106.64%165.86K
-1,600.59%-4.55M
77.98%-248.37K
76.22%-329.29K
-165.39%-1.47M
-540.73%-2.5M
-Change in other current assets
--0
--0
--0
--0
--0
136.99%212.88K
201.48%118.3K
--32.43K
--31.29K
-39.00%30.86K
-Change in other current liabilities
--0
--0
--0
--0
--0
-116.13%-209.02K
-179.94%-117.95K
-3,648.76%-36.14K
---21.18K
37.05%-33.75K
Cash from discontinued investing activities
Operating cash flow
82.04%-3.27M
71.14%-332.78K
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.45%-18.22M
87.19%-1.15M
77.59%-2.52M
12.12%-10.93M
55.97%-3.62M
Investing cash flow
Cash flow from continuing investing activities
77.98%-132.12K
0
0
-4,094.63%-600K
0
-23,337.80%-600K
Net PPE purchase and sale
----
----
----
----
----
--0
--0
--0
----
----
Net investment purchase and sale
---132.12K
--0
--0
----
----
--0
--0
--0
----
----
Net other investing changes
----
----
----
----
----
---600K
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
77.98%-132.12K
--0
--0
---132.12K
--0
-4,094.63%-600K
--0
-23,337.80%-600K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
10.93%4.83M
-160.24K
-106.29%-157.35K
-154.52K
186.39%5.3M
-3.23%4.35M
0
2.5M
0
1.85M
Net issuance payments of debt
---3.37M
---160.24K
---157.35K
---154.52K
---2.9M
--0
--0
--0
--0
--0
Net common stock issuance
--0
--0
----
----
386.56%9M
--2.5M
--0
----
----
--1.85M
Proceeds from stock option exercised by employees
386.56%9M
--0
--0
----
----
-58.85%1.85M
--0
--0
--0
--1.85M
Net other financing activities
---802.6K
--0
--0
--0
---802.6K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
10.93%4.83M
---160.24K
-106.29%-157.35K
---154.52K
186.39%5.3M
-3.23%4.35M
--0
--2.5M
--0
--1.85M
Net cash flow
Beginning cash position
-97.25%406.41K
55.04%2.32M
38.27%2.92M
-65.00%4.59M
-97.25%406.41K
-71.12%14.79M
-92.24%1.5M
-93.07%2.12M
-69.52%13.11M
-71.12%14.79M
Current changes in cash
109.83%1.42M
57.24%-493.02K
2.37%-603.32K
84.79%-1.66M
336.55%4.18M
60.27%-14.47M
74.42%-1.15M
94.50%-617.93K
12.24%-10.93M
78.49%-1.77M
Effect of exchange rate changes
--0
--0
--0
--0
--0
1,634.16%87.12K
593.00%62.18K
99.77%-9
-229.53%-61.75K
361.61%86.71K
End cash Position
349.81%1.83M
349.81%1.83M
55.04%2.32M
38.27%2.92M
-65.00%4.59M
-97.25%406.41K
-97.25%406.41K
-92.24%1.5M
-93.07%2.12M
-69.52%13.11M
Free cash flow
82.04%-3.27M
71.14%-332.78K
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.46%-18.22M
87.19%-1.15M
77.59%-2.52M
12.24%-10.93M
55.97%-3.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 82.04%-3.27M71.14%-332.78K82.29%-445.96K87.42%-1.38M69.10%-1.12M55.45%-18.22M87.19%-1.15M77.59%-2.52M12.12%-10.93M55.97%-3.62M
Net income from continuing operations 37.25%-8.28M57.55%-656.89K90.29%-472.51K73.44%-1.04M-113.96%-6.11M73.04%-13.19M86.01%-1.55M53.78%-4.87M72.12%-3.93M78.48%-2.85M
Operating gains losses 173.30%4.09M103.23%34.62K29.31%-47.28K78.71%-698.07K513.60%4.8M-523.43%-5.58M---1.07M---66.88K---3.28M---1.16M
Depreciation and amortization --0--0--0--0--0-54.18%30.76K--0--0--070.53%30.76K
Deferred tax ----------------------0----------------
Other non cash items --------------------512.70%1.82M405.48%794.25K438.98%474.57K-1,313.48%-1.25M3,610.29%1.8M
Change In working capital 118.38%493.05K552.92%289.49K-96.14%73.82K98.50%-37.46K107.83%167.2K-190.30%-2.68M102.28%44.34K310.84%1.91M-190.26%-2.5M-170.07%-2.14M
-Change in prepaid assets -73.55%491.62K-39.37%177.27K-92.79%161.91K114.49%151.09K-99.63%1.34K-30.51%1.86M135.99%292.36K368.68%2.24M-298.98%-1.04M-85.34%364.26K
-Change in payables and accrued expense 100.03%1.43K145.18%112.22K73.25%-88.09K87.18%-188.55K106.64%165.86K-1,600.59%-4.55M77.98%-248.37K76.22%-329.29K-165.39%-1.47M-540.73%-2.5M
-Change in other current assets --0--0--0--0--0136.99%212.88K201.48%118.3K--32.43K--31.29K-39.00%30.86K
-Change in other current liabilities --0--0--0--0--0-116.13%-209.02K-179.94%-117.95K-3,648.76%-36.14K---21.18K37.05%-33.75K
Cash from discontinued investing activities
Operating cash flow 82.04%-3.27M71.14%-332.78K82.29%-445.96K87.42%-1.38M69.10%-1.12M55.45%-18.22M87.19%-1.15M77.59%-2.52M12.12%-10.93M55.97%-3.62M
Investing cash flow
Cash flow from continuing investing activities 77.98%-132.12K00-4,094.63%-600K0-23,337.80%-600K
Net PPE purchase and sale ----------------------0--0--0--------
Net investment purchase and sale ---132.12K--0--0----------0--0--0--------
Net other investing changes -----------------------600K--0------------
Cash from discontinued investing activities
Investing cash flow 77.98%-132.12K--0--0---132.12K--0-4,094.63%-600K--0-23,337.80%-600K--0--0
Financing cash flow
Cash flow from continuing financing activities 10.93%4.83M-160.24K-106.29%-157.35K-154.52K186.39%5.3M-3.23%4.35M02.5M01.85M
Net issuance payments of debt ---3.37M---160.24K---157.35K---154.52K---2.9M--0--0--0--0--0
Net common stock issuance --0--0--------386.56%9M--2.5M--0----------1.85M
Proceeds from stock option exercised by employees 386.56%9M--0--0---------58.85%1.85M--0--0--0--1.85M
Net other financing activities ---802.6K--0--0--0---802.6K--------------------
Cash from discontinued financing activities
Financing cash flow 10.93%4.83M---160.24K-106.29%-157.35K---154.52K186.39%5.3M-3.23%4.35M--0--2.5M--0--1.85M
Net cash flow
Beginning cash position -97.25%406.41K55.04%2.32M38.27%2.92M-65.00%4.59M-97.25%406.41K-71.12%14.79M-92.24%1.5M-93.07%2.12M-69.52%13.11M-71.12%14.79M
Current changes in cash 109.83%1.42M57.24%-493.02K2.37%-603.32K84.79%-1.66M336.55%4.18M60.27%-14.47M74.42%-1.15M94.50%-617.93K12.24%-10.93M78.49%-1.77M
Effect of exchange rate changes --0--0--0--0--01,634.16%87.12K593.00%62.18K99.77%-9-229.53%-61.75K361.61%86.71K
End cash Position 349.81%1.83M349.81%1.83M55.04%2.32M38.27%2.92M-65.00%4.59M-97.25%406.41K-97.25%406.41K-92.24%1.5M-93.07%2.12M-69.52%13.11M
Free cash flow 82.04%-3.27M71.14%-332.78K82.29%-445.96K87.42%-1.38M69.10%-1.12M55.46%-18.22M87.19%-1.15M77.59%-2.52M12.24%-10.93M55.97%-3.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -